drugset / Trial / NCT00033306
BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
Phase 2
Terminated
2 enrolled
University of Alabama at Birmingham
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BMS-247550 in treating patients who have metastatic colorectal cancer.
Timeline
- Start
- 2002-02
- Primary completion
- 2005-07
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ixabepilone | Small molecule | — | Intravenous |
| Background | Irinotecan | Small molecule | — | — |